Third Rock Ventures
Venture capital · Boston, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
56Deep-tech portfolio26 active
30Portfolio exitsAcquired or listed
2Raises, 12 monthsLatest: Terremoto Biosciences
88Co-investorsShare a portfolio company
Portfolio companies’ first raises and first grants, by year
First raisesFirst federal grants
The year each portfolio company first filed a Form D, and first won a federal grant. These describe the companies, not when this investor joined them.
Portfolio · 56 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Terremoto Biosciences | Biotech | Active | Apr 22, 2026 | $40.7M |
| Corvia Medical | Medtech | Active | Jun 25, 2025 | $42.9M |
| Marea Therapeutics | Biotech | Active | Jun 24, 2024 | $65.4M |
| Synnovation Therapeutics | Biotech | Active | Dec 21, 2023 | $106.9M |
| Frontier Medicines | Biotech | Active | Jul 12, 2021 | $122.0M |
| Prelude Therapeutics | Biotech | Active | Aug 28, 2020 | $97.0M |
| Insitro | Biotech | Active | May 27, 2020 | $143.2M |
| Navitor Pharmaceuticals | Biotech | Active | May 7, 2020 | $64.9M |
| Nurix Therapeutics | Biotech | Active | Mar 26, 2020 | $142.5M |
| Lyell Immunopharma | Biotech | Active | Mar 20, 2020 | $493.0M |
| Arrakis Therapeutics | Biotech | Active | Apr 18, 2019 | $28.2M |
| ARTBIO | Biotech | Active | — | — |
| Azalea Therapeutics | Biotech | Active | — | — |
| BE Biopharma | Biotech | Active | — | — |
| Clasp Therapeutics | Biotech | Active | — | — |
| Corxel | Biotech | Active | — | — |
| Flare Therapeutics | Biotech | Active | — | — |
| Foghorn Therapeutics | Biotech | Active | — | — |
| Inflection Medicine | Biotech | Active | — | — |
| Maze Therapeutics | Biotech | Active | — | — |
| Merida Biosciences | Biotech | Active | — | — |
| Nimbus Therapeutics | Biotech | Active | — | — |
| Rapport Therapeutics | Biotech | Active | — | — |
| Replimune | Biotech | Active | — | — |
| Syremis Therapeutics | Biotech | Active | — | — |
| Trace Neuroscience | Biotech | Active | — | — |
| Tango Therapeutics | Biotech | Public | Oct 28, 2025 | $95.0M |
| Seaport Therapeutics | Biotech | Public | Oct 31, 2024 | $225.9M |
| Candid Therapeutics | Biotech | Acquired | Sep 13, 2024 | $206.2M |
| Ajax Therapeutics | Biotech | Acquired | May 13, 2024 | $140.4M |
| Jnana Therapeutics | Biotech | Acquired | Jan 26, 2024 | $110.0M |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Septerna | Biotech | Public | Jul 13, 2023 | $73.5M |
| Entrada Therapeutics | Biotech | Public | Apr 13, 2021 | $150.9M |
| TScan Therapeutics | Biotech | Public | Jan 28, 2021 | $123.3M |
| Sage Therapeutics | Biotech | Acquired | Jan 15, 2021 | $698.0M |
| Imago BioSciences | Biotech | Acquired | Nov 20, 2020 | $105.8M |
| Decibel Therapeutics | Biotech | Acquired | Nov 12, 2020 | $62.8M |
| Vor Biopharma | Biotech | Public | Jul 10, 2020 | $110.1M |
| Fulcrum Therapeutics | Biotech | Public | Jun 11, 2020 | $170.5M |
| Atea Pharmaceuticals | Biotech | Public | May 29, 2020 | $155.9M |
| Black Diamond Therapeutics | Biotech | Public | Dec 6, 2019 | $139.6M |
| Passage Bio | Biotech | Public | Sep 6, 2019 | $110.0M |
| Translate Bio | Biotech | Acquired | May 10, 2019 | $98.5M |
| Pandion Therapeutics | Biotech | Acquired | Jan 22, 2018 | $21.6M |
| C4 Therapeutics | Biotech | Public | Jan 11, 2016 | $70.3M |
| Scholar Rock | Biotech | Public | Jan 4, 2016 | $36.3M |
| Dimension Therapeutics | Biotech | Acquired | Apr 23, 2015 | $70.0M |
| Global Blood Therapeutics | Biotech | Acquired | Jan 5, 2015 | $48.0M |
| Blueprint Medicines | Biotech | Acquired | Nov 20, 2014 | $73.2M |
| Civitas Therapeutics | Biotech | Acquired | Aug 29, 2014 | $103.5M |
| Agios Pharmaceuticals | Biotech | Public | Nov 22, 2011 | $86.8M |
| Armo Biosciences | Biotech | Acquired | — | — |
| Bicycle Therapeutics | Biotech | Public | — | — |
| Karuna Therapeutics | Biotech | Acquired | — | — |
| Versartis | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#5
Portfolio exits#1
Raises, 12 months#12
Co-investors#2
Co-investors
- RA CapitalVenture capital15 shared
- Perceptive AdvisorsVenture capital8 shared
- Atlas VentureVenture capital7 shared
- ARCH VentureVenture capital6 shared
- Deerfield Capital ManagementVenture capital6 shared
- Omega FundsVenture capital6 shared
- Foresite CapitalVenture capital5 shared
- Biotechnology Value FundVenture capital4 shared
- Boxer CapitalVenture capital4 shared
- Gurnet Point CapitalVenture capital4 shared
Sectors
- Biotech55
- Medtech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.